This inventor holds 9 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 8 EPO patents. Top assignees: Singapore Health Services Pte Ltd, Agency for Science, Technology and Research, Nanyang Technological University. Active years: 2011-2025.
Company Filing History:
9 out of 140 
5 out of 1,560 
2 out of 682 
Years Active: 2011-2025
Title: **Innovations and Contributions of Roger Wilmer Beuerman**
Introduction
Roger Wilmer Beuerman is a renowned inventor based in Singapore, known for his significant contributions to the fields of ophthalmology and antimicrobial research. With a total of eight patents, Dr. Beuerman has made noteworthy advancements that aim to improve patient outcomes and address prevalent health issues.
Latest Patents
Among his latest innovations are two pivotal patents. The first is an agent for preventing, treating, and/or preventing the progression of myopia, which features tiotropium as its active ingredient. This invention aims to offer a therapeutic solution for individuals experiencing myopia. The second patent focuses on antimicrobial peptides that include epsilon lysine residues. This patent details a peptide composition that boasts reduced cytotoxicity compared to non-modified counterparts and has significant implications in managing microbial colonization and treating various diseases.
Career Highlights
Dr. Beuerman has held key positions within esteemed organizations such as Singapore Health Services Pte Ltd and the Agency for Science, Technology and Research. His professional journey reflects a commitment to advancing medical science and improving therapeutic methods through innovative research and development.
Collaborations
Throughout his career, Dr. Beuerman has collaborated with prominent colleagues like Shouping Liu and Lei Zhou. These partnerships have been instrumental in driving research initiatives forward and developing groundbreaking patents that contribute to modern medicine.
Conclusion
Roger Wilmer Beuerman stands as a distinguished inventor whose work has not only yielded multiple patents but has also paved the way for future innovations in myopia treatment and antimicrobial therapies. His continued efforts in research reflect a dedication to enhancing healthcare solutions and patient well-being.